how has the presence or lack of data changed drug development for platelet disorders?
Published 3 years ago • 22 plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
53:31
a continuity of drug development for diseases across the lifespan
-
3:27
what does the fda hope to achieve through developing the rare disease cures accelerator?
-
30:31
drug development and regulation in the age of precision medicine
-
3:55
platelet disorders made easy! lifecycle and classification
-
2:08
platelet activation and factors for clot formation
-
7:24
low platelets: what causes it, how do you treat it?
-
13:53
i am an itp patient- how i increased a low blood platelet count. :)
-
1:24:51
mds 2023: ps 2 - from clonal hematopoiesis to overt mds
-
1:10:15
sbs day 2 - session iii-b: disease prevention in lysosomal diseases
-
28:00
basics of rare platelet disorders
-
10:45
platelet abnormalities and disorders
-
6:45
blood review series - clinical platelet disorders
-
1:02:39
racing against time: a new approach to battling heart attack
-
1:32
platelet disorders | pathology promotion video | medical education | v-learning
-
1:09:23
stem cell to t cell: molecular anatomy of commitment
-
27:00
ph-ild: does treatment improve outcomes? | steve nathan, md
-
4:50:23
clinical gene therapy: asgct indo-uk symposium
-
2:16
klaus romero - what does c-path do?
-
1:00:00
comprehensive management for patients with bone marrow failure conditions | upmc children's
-
1:05:33
procalcitonin and its importance in the emergency department
-
3:55
peng block: 3 potential outcomes